FOLFOX-6 PLUS IMATINIB, BEVACIZUMAB AND CETUXIMAB IN ADVANCED UNTREATED COLORECTAL CANCER

被引：0
|
作者：
Andretta, V [1 ]
Bennicelli, E. [1 ]
Pessino, A. [1 ]
Caprioni, F. [1 ]
Decian, F. [1 ]
Di Benedetto, M. [1 ]
Sobrero, A. [1 ]
机构：
[1] Azienda Osped Univ San Martino Genova, Genoa, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer
    M. Michael
    J. Zalcberg
    P. Gibbs
    L. Lipton
    M. Gouillou
    M. Jefford
    G. McArthur
    M. Copeman
    K. Lynch
    N. C. Tebbutt
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 321 - 330
  • [42] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
  • [43] Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer
    Saltz, Leonard
    Badarinath, Suprith
    Dakhil, Shaker
    Bienvenu, Bryan
    Harker, W. Graydon
    Birchfield, George
    Tokaz, Laurence K.
    Barrera, David
    Conkling, Paul R.
    O'Rourke, Mark A.
    Richards, Donald A.
    Reidy, Diane
    Solit, David
    Vakiani, Efsevia
    Capanu, Marinella
    Scales, Amy
    Zhan, Feng
    Boehm, Kristi A.
    Asmar, Lina
    Cohn, Allen
    CLINICAL COLORECTAL CANCER, 2012, 11 (02) : 101 - 111
  • [44] Randomized phase 2 study of DKN-01 plus FOLFIRI/FOLFOX and bevacizumab versus FOLFIRI/FOLFOX and bevacizumab as second-line treatment of advanced colorectal cancer (DeFianCe).
    Wainberg, Zev A.
    Boccia, Ralph V.
    Strickler, John H.
    Moehler, Markus H.
    Sirard, Cynthia A.
    Walsh, Erin K.
    Parker, Elizabeth C.
    Lee, Keun-Wook
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS275 - TPS275
  • [45] Cetuximab and FOLFOX-4 in metastasized colorectal Cancer
    Kuetting, Fabian
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (12): : 1034 - 1036
  • [46] A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer
    R K Kelley
    J Hwang
    M J M Magbanua
    L Watt
    J H Beumer
    S M Christner
    S Baruchel
    B Wu
    L Fong
    B M Yeh
    A P Moore
    A H Ko
    W M Korn
    S Rajpal
    J W Park
    M A Tempero
    A P Venook
    E K Bergsland
    British Journal of Cancer, 2013, 109 : 1725 - 1734
  • [47] A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer
    Kelley, R. K.
    Hwang, J.
    Magbanua, M. J. M.
    Watt, L.
    Beumer, J. H.
    Christner, S. M.
    Baruchel, S.
    Wu, B.
    Fong, L.
    Yeh, B. M.
    Moore, A. P.
    Ko, A. H.
    Korn, W. M.
    Rajpal, S.
    Park, J. W.
    Tempero, M. A.
    Venook, A. P.
    Bergsland, E. K.
    BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1725 - 1734
  • [48] A prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver metastasis
    Ji, Jun Ho
    Park, Young Suk
    Lee, Jeeyun
    Kim, Tae Won
    Hong, Yong Sang
    Kim, Kyu-Pyo
    Kim, Sun Young
    Baek, Ji Yeon
    Kang, Hye Jin
    Shin, Sang Joon
    Shim, Byoung Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
    Tol, Jolien
    Koopman, Miriam
    Cats, Annemieke
    Rodenburg, Cees J.
    Creemers, Geert J. M.
    Schrama, Jolanda G.
    Erdkamp, Frans L. G.
    Vos, Allert H.
    van Groeningen, Cees J.
    Sinnige, Harm A. M.
    Richel, Dirk J.
    Voest, Emile E.
    Dijkstra, Jeroen R.
    Vink-Borger, Marianne E.
    Antonini, Ninja F.
    Mol, Linda
    van Krieken, Johan H. J. M.
    Dalesio, Otilia
    Punt, Cornelis J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06): : 563 - 572
  • [50] A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ? Bevacizumab versus FOLFOX ? Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
    Wang, Feng
    He, Ming -Ming
    Xiao, Jian
    Zhang, Yan-Qiao
    Yuan, Xiang-Lin
    Fang, Wei-Jia
    Zhang, Yan
    Wang, Wei
    Hu, Xiao-Hua
    Ma, Zhi-Gang
    Yao, Yi-Chen
    Zhuang, Zhi-Xiang
    Zhou, Fu-Xiang
    Ying, Jie-Er
    Yuan, Ying
    Zou, Qing-Feng
    Guo, Zeng-Qing
    Wu, Xiang-Yuan
    Jin, Ying
    Mai, Zong-Jiong
    Wang, Zhi-Qiang
    Qiu, Hong
    Guo, Ying
    Shi, Si -Mei
    Chen, Shuang-Zhen
    Luo, Hui-Yan
    Zhang, Dong-Sheng
    Wang, Feng-Hua
    Li, Yu-Hong
    Xu, Rui-Hua
    CLINICAL CANCER RESEARCH, 2022, 28 (19) : 4232 - 4239
12345